TY - JOUR
T1 - Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP
T2 - A nationwide study in Japan
AU - Hato, Takaaki
AU - Shimada, Naoki
AU - Kurata, Yoshiyuki
AU - Kuwana, Masataka
AU - Fujimura, Kingo
AU - Kashiwagi, Hirokazu
AU - Takafuta, Toshiro
AU - Murata, Mitsuru
AU - Tomiyama, Yoshiaki
N1 - Funding Information:
This study was supported by a Grant-in-Aid for scientific research on blood coagulation abnormalities from the Ministry of Health, Labour, and Welfare of Japan (H29-Nanchitou-General-012).
Publisher Copyright:
© 2020 by The American Society of Hematology.
PY - 2020/4/28
Y1 - 2020/4/28
N2 - Bleeding manifestations in primary immune thrombocytopenia (ITP) range from skin petechiae to life-threatening intracranial hemorrhage (ICH). However, the relation between these various bleeding manifestations and the platelet count in ITP remains poorly characterized. Using a nationwide database of patients with ITP during the years 2005 to 2014 (10 years) in Japan, we analyzed 19 415 adult patients newly diagnosed with ITP, including 222 with ICH. The frequency of skin purpura was 64.8%, and this increased linearly with thrombocytopenia without a specific platelet count threshold. In contrast, mucosal bleeding (epistaxis and gingival bleeding) and organ bleeding (melena, hematuria, and ICH) increased exponentially with thrombocytopenia at a platelet count threshold of 10 to 15 × 109/L. Age showed a much weaker correlation than platelet count with skin and mucosal bleeding. However, the incidence of organ bleeding increased exponentially above 60 years of age. Multivariate analysis showed that the presence of mucosal bleeding was a risk factor for occurrence of melena and hematuria but not for ICH. The frequency of ICH was 1.1% and risk factors for ICH were age ≥60 years (odds ratio [OR], 3.09; 95% confidence interval [CI], 2.13-4.47; P< .001), platelet count<10 × 109/L (OR, 2.96; 95% CI, 2.11-4.15; P< .001), and the presence of hematuria (OR, 1.56; 95% CI, 1.04-2.35; P = .033). The relation between ICH and platelet count varied with age. This large-scale analysis of risk factors for bleeding in ITP has revealed distinct characteristics of skin, mucosal, and organ bleeding in adult patients with newly diagnosed ITP, thus indicating those who are at a high risk of severe organ bleeding.
AB - Bleeding manifestations in primary immune thrombocytopenia (ITP) range from skin petechiae to life-threatening intracranial hemorrhage (ICH). However, the relation between these various bleeding manifestations and the platelet count in ITP remains poorly characterized. Using a nationwide database of patients with ITP during the years 2005 to 2014 (10 years) in Japan, we analyzed 19 415 adult patients newly diagnosed with ITP, including 222 with ICH. The frequency of skin purpura was 64.8%, and this increased linearly with thrombocytopenia without a specific platelet count threshold. In contrast, mucosal bleeding (epistaxis and gingival bleeding) and organ bleeding (melena, hematuria, and ICH) increased exponentially with thrombocytopenia at a platelet count threshold of 10 to 15 × 109/L. Age showed a much weaker correlation than platelet count with skin and mucosal bleeding. However, the incidence of organ bleeding increased exponentially above 60 years of age. Multivariate analysis showed that the presence of mucosal bleeding was a risk factor for occurrence of melena and hematuria but not for ICH. The frequency of ICH was 1.1% and risk factors for ICH were age ≥60 years (odds ratio [OR], 3.09; 95% confidence interval [CI], 2.13-4.47; P< .001), platelet count<10 × 109/L (OR, 2.96; 95% CI, 2.11-4.15; P< .001), and the presence of hematuria (OR, 1.56; 95% CI, 1.04-2.35; P = .033). The relation between ICH and platelet count varied with age. This large-scale analysis of risk factors for bleeding in ITP has revealed distinct characteristics of skin, mucosal, and organ bleeding in adult patients with newly diagnosed ITP, thus indicating those who are at a high risk of severe organ bleeding.
UR - http://www.scopus.com/inward/record.url?scp=85084237929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084237929&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2020001446
DO - 10.1182/bloodadvances.2020001446
M3 - Article
C2 - 32320469
AN - SCOPUS:85084237929
SN - 2473-9529
VL - 4
SP - 1648
EP - 1655
JO - Blood Advances
JF - Blood Advances
IS - 8
ER -